LinkedIn
ALOOSTA
Contact
The validity period for the approval for 50 active substances has been extended by one year due to the delay in the re-evaluation following the application for renewal of the approval.
We list the organic active ingredients only.
|
Active ingredients |
limited until |
Reference |
|
1-Naphthyl-acetamide |
31.03.2027 |
1) |
|
1-Naphthyl-acetic acid |
31.03.2027 |
|
|
2-Phenylphenol (incl. its salts such as sodium salt) |
15.11.2027 |
|
|
8-Hydroxyquinoline |
31.12.2024 |
|
|
Amidosulfuron |
15.08.2025 |
|
|
Bifenox |
31.03.2027 |
|
|
Dicamba |
31.03.2027 |
|
|
Difenoconazole |
15.03.3026 |
|
|
Diflufenican |
15.01.2026 |
|
|
Dimethachlor |
15.10.2026 |
|
|
Esfenvalerate |
31.03.2027 |
|
|
Etofenprox |
31.03.2027 |
|
|
Fenoxaprop-P |
15.08.2025 |
|
|
Fenpropidin |
15.05.2027 |
|
|
Fenpyrazamine |
31.03.2027 |
|
|
Fluazifop-P |
31.03.2027 |
|
|
Lenacil |
15.08.2025 |
|
|
Napropamide |
31.03.2027 |
|
|
Nicosulfuron |
31.03.2027 |
|
|
Paraffin oil |
15.08.2025 |
|
|
Paraffin oils |
31.03.2027 |
|
|
Penconazole |
15.10.2026 |
|
|
Picloram |
15.02.2028 |
|
|
Prohexadione |
31.03.2027 |
|
|
Spiroxamine |
31.03.2027 |
|
|
Sulphur |
15.04.2025 |
|
|
Tretraconazole |
31.03.2027 |
|
|
Triallate |
31.03.2027 |
|
|
Ethephon |
31.01.2039 |
2) |
1) Commission Implementing Regulation (EU) 2023/2592 by 11/21/23 amending Implementing Regulation (EU) No 540/2011
2) Commission Implementing Regulation (EU) 2023/259 by 11/21/23 amending Implementing Regulation (EU) No 540/2011
If the review for any of the active ingredients leads to rejection of the renewal application in the meantime, the approval will expire with a corresponding order ahead of schedule. The lifetime extensions have no influence on the current maximum residue limits.
Author: Dr. Frank Mörsberger
Contact
Career